Does BOSENTAN Cause Interstitial lung disease? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Interstitial lung disease have been filed in association with BOSENTAN (Tracleer). This represents 0.4% of all adverse event reports for BOSENTAN.
71
Reports of Interstitial lung disease with BOSENTAN
0.4%
of all BOSENTAN reports
28
Deaths
40
Hospitalizations
How Dangerous Is Interstitial lung disease From BOSENTAN?
Of the 71 reports, 28 (39.4%) resulted in death, 40 (56.3%) required hospitalization, and 3 (4.2%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOSENTAN. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does BOSENTAN Cause?
Dyspnoea (2,492)
Death (2,388)
Pneumonia (1,064)
Fatigue (1,025)
Headache (962)
Hospitalisation (915)
Malaise (894)
Diarrhoea (840)
Product dose omission issue (798)
Pulmonary arterial hypertension (778)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BOSENTAN Alternatives Have Lower Interstitial lung disease Risk?
BOSENTAN vs BOSENTAN\BOSENTAN
BOSENTAN vs BOSUTINIB
BOSENTAN vs BOTOX
BOSENTAN vs BOTOX COSMETIC
BOSENTAN vs BOTULINUM TOXIN NOS